Login
Super Investors WEBER CAPITAL MANAGEMENT LLC /ADV
WC

WEBER CAPITAL MANAGEMENT LLC /ADV

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$110M
Positions
13
Quarter ended
September 30, 2026
Filed
October 19, 2026

Reported portfolio value by quarter (4 quarters reported)

$118M $100M
Q4 25 Q1 26 Q2 26 Q3 26

$106M in Q4 2025 → $110M now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
Mistras Group Inc 26.1% Trimmed 6.1% 1,360,146 $28.6M
Angiodynamics Inc 18.9% Trimmed 0.5% 1,349,902 $20.8M
NG Natural Gas Svcs Group Inc 14.2% Unchanged 479,712 $15.5M
A& Alpha & Omega Semiconductor 13.5% Trimmed 0.3% 536,737 $14.8M
TM Telos Corp Md 6.5% Trimmed 0.7% 1,754,120 $7.14M
CI Cra Intl Inc 5.6% Unchanged 37,606 $6.17M
IT Ishares Tr 4.7% Added 56% 28,078 $5.19M
Aviat Networks Inc 2.6% Unchanged 141,172 $2.83M
TM Treace Med Concepts Inc 2.4% Unchanged 589,617 $2.62M
Harvard Bioscience Inc 2.2% Trimmed 3.6% 299,816 $2.37M
Hackett Group Inc 2.1% Unchanged 225,663 $2.27M
AD Accuray Inc Del 1.2% Trimmed 2.0% 4,832,616 $1.31M
Iridex Corp 0.1% Trimmed 19% 146,980 $92.6K

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 3 quarters.

Q3 2026

quarter ended September 30, 2026 · filed October 19, 2026

Company Action Shares changed Value of change % of portfolio
IT Ishares Tr Added +10,095 +$1.87M 4.7%
Mistras Group Inc Trimmed −88,008 −$1.85M 26.1%
Angiodynamics Inc Trimmed −6,700 −$103K 18.9%
Harvard Bioscience Inc Trimmed −11,045 −$87.5K 2.2%
TM Telos Corp Md Trimmed −12,400 −$50.5K 6.5%
A& Alpha & Omega Semiconductor Trimmed −1,700 −$46.8K 13.5%
AD Accuray Inc Del Trimmed −100,090 −$27K 1.2%
Iridex Corp Trimmed −33,471 −$21.1K 0.1%

Q2 2026

quarter ended June 30, 2026 · filed August 13, 2026

Company Action Shares changed Value of change % of portfolio
Cantaloupe Inc Exited −523,884 −$5.66M —
Angiodynamics Inc Trimmed −16,547 −$215K 15.0%
A& Alpha & Omega Semiconductor Trimmed −3,871 −$183K 21.7%
Mistras Group Inc Trimmed −8,815 −$154K 21.5%
Iridex Corp Trimmed −79,107 −$90.6K 0.2%
NG Natural Gas Svcs Group Inc Trimmed −2,052 −$88.5K 17.6%
Harvard Bioscience Inc Trimmed −9,176 −$56.4K 1.6%
Aviat Networks Inc Trimmed −1,736 −$38.5K 2.7%
AD Accuray Inc Del Trimmed −122,588 −$31.6K 1.1%

Q1 2026

quarter ended March 31, 2026 · filed April 23, 2026

Company Action Shares changed Value of change % of portfolio
Harvard Bioscience Inc Exited −3,200,380 −$2.14M —
Harvard Bioscience Inc New +320,037 +$1.56M 1.6%
NG Natural Gas Svcs Group Inc Trimmed −16,817 −$635K 18.2%
Cantaloupe Inc Trimmed −40,000 −$432K 5.7%
Mistras Group Inc Trimmed −25,133 −$371K 21.5%
Angiodynamics Inc Trimmed −27,000 −$307K 15.6%
CI Cra Intl Inc Trimmed −1,494 −$242K 6.1%
TM Telos Corp Md Trimmed −28,000 −$117K 7.4%
A& Alpha & Omega Semiconductor Trimmed −5,000 −$111K 12.0%
Hackett Group Inc Trimmed −8,000 −$104K 2.9%

Showing the 10 largest of 11 changes.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support